nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—CYP3A4—bone cancer	0.733	1	CbGaD
Clobazam—CYP2B6—Cisplatin—bone cancer	0.0428	0.326	CbGbCtD
Clobazam—CYP2B6—Doxorubicin—bone cancer	0.0287	0.219	CbGbCtD
Clobazam—ABCB1—Cisplatin—bone cancer	0.022	0.167	CbGbCtD
Clobazam—ABCB1—Doxorubicin—bone cancer	0.0147	0.112	CbGbCtD
Clobazam—ABCB1—Methotrexate—bone cancer	0.0143	0.109	CbGbCtD
Clobazam—CYP3A4—Doxorubicin—bone cancer	0.00882	0.0672	CbGbCtD
Clobazam—CYP2C18—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00298	0.063	CbGpPWpGaD
Clobazam—Slurred speech—Cisplatin—bone cancer	0.00268	0.0335	CcSEcCtD
Clobazam—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00146	0.031	CbGpPWpGaD
Clobazam—Infection—Carboplatin—bone cancer	0.00145	0.0181	CcSEcCtD
Clobazam—CYP2C18—Xenobiotics—CYP3A4—bone cancer	0.00144	0.0304	CbGpPWpGaD
Clobazam—Loss of libido—Methotrexate—bone cancer	0.00143	0.0178	CcSEcCtD
Clobazam—Appetite absent—Methotrexate—bone cancer	0.00132	0.0165	CcSEcCtD
Clobazam—CYP2C18—Metapathway biotransformation—CYP4V2—bone cancer	0.00128	0.0271	CbGpPWpGaD
Clobazam—Dysarthria—Cisplatin—bone cancer	0.00127	0.0158	CcSEcCtD
Clobazam—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00123	0.026	CbGpPWpGaD
Clobazam—Body temperature increased—Carboplatin—bone cancer	0.00115	0.0144	CcSEcCtD
Clobazam—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00111	0.0234	CbGpPWpGaD
Clobazam—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00108	0.023	CbGpPWpGaD
Clobazam—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00102	0.0215	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00102	0.0215	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00101	0.0215	CbGpPWpGaD
Clobazam—Amnesia—Cisplatin—bone cancer	0.000927	0.0116	CcSEcCtD
Clobazam—Nystagmus—Epirubicin—bone cancer	0.000863	0.0108	CcSEcCtD
Clobazam—Clomipramine—GSTP1—bone cancer	0.000845	0.0977	CrCbGaD
Clobazam—Irritability—Cisplatin—bone cancer	0.000832	0.0104	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—TGFBR2—bone cancer	0.00083	0.0176	CbGpPWpGaD
Clobazam—SLC6A11—NRF2 pathway—GSTP1—bone cancer	0.00083	0.0176	CbGpPWpGaD
Clobazam—Nystagmus—Doxorubicin—bone cancer	0.000799	0.00997	CcSEcCtD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000791	0.0167	CbGpPWpGaD
Clobazam—Blood disorder—Epirubicin—bone cancer	0.000738	0.00921	CcSEcCtD
Clobazam—CYP2C18—Tryptophan metabolism—CYP3A4—bone cancer	0.000738	0.0156	CbGpPWpGaD
Clobazam—Musculoskeletal stiffness—Methotrexate—bone cancer	0.000734	0.00916	CcSEcCtD
Clobazam—GABRB2—Orphan transporters—TUBB4B—bone cancer	0.00073	0.0154	CbGpPWpGaD
Clobazam—Delirium—Epirubicin—bone cancer	0.000717	0.00895	CcSEcCtD
Clobazam—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000706	0.015	CbGpPWpGaD
Clobazam—Hepatic enzyme increased—Methotrexate—bone cancer	0.000696	0.00869	CcSEcCtD
Clobazam—Dysarthria—Methotrexate—bone cancer	0.000696	0.00869	CcSEcCtD
Clobazam—Blood disorder—Doxorubicin—bone cancer	0.000683	0.00852	CcSEcCtD
Clobazam—Respiratory failure—Methotrexate—bone cancer	0.000671	0.00837	CcSEcCtD
Clobazam—SLC6A1—NRF2 pathway—TGFBR2—bone cancer	0.000669	0.0142	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—GSTP1—bone cancer	0.000669	0.0142	CbGpPWpGaD
Clobazam—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000667	0.0141	CbGpPWpGaD
Clobazam—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000665	0.0141	CbGpPWpGaD
Clobazam—Delirium—Doxorubicin—bone cancer	0.000663	0.00828	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000653	0.0138	CbGpPWpGaD
Clobazam—Dysarthria—Epirubicin—bone cancer	0.000652	0.00813	CcSEcCtD
Clobazam—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.00063	0.0133	CbGpPWpGaD
Clobazam—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.00063	0.0133	CbGpPWpGaD
Clobazam—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000626	0.0132	CbGpPWpGaD
Clobazam—Antipyrine—CYP3A4—bone cancer	0.000618	0.0714	CrCbGaD
Clobazam—Antipyrine—PTGS2—bone cancer	0.000605	0.0699	CrCbGaD
Clobazam—Dysarthria—Doxorubicin—bone cancer	0.000603	0.00753	CcSEcCtD
Clobazam—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000597	0.0126	CbGpPWpGaD
Clobazam—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000593	0.0126	CbGpPWpGaD
Clobazam—CYP2C18—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000589	0.0125	CbGpPWpGaD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000583	0.0124	CbGpPWpGaD
Clobazam—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000583	0.0123	CbGpPWpGaD
Clobazam—Visual impairment—Cisplatin—bone cancer	0.000581	0.00725	CcSEcCtD
Clobazam—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.000576	0.0122	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000564	0.0119	CbGpPWpGaD
Clobazam—Eye disorder—Cisplatin—bone cancer	0.000563	0.00703	CcSEcCtD
Clobazam—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000534	0.0113	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000526	0.0111	CbGpPWpGaD
Clobazam—Malnutrition—Cisplatin—bone cancer	0.000525	0.00655	CcSEcCtD
Clobazam—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000513	0.0109	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—NDUFA12—bone cancer	0.00051	0.0108	CbGpPWpGaD
Clobazam—Muscle spasms—Cisplatin—bone cancer	0.000505	0.0063	CcSEcCtD
Clobazam—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000504	0.0107	CbGpPWpGaD
Clobazam—Vision blurred—Cisplatin—bone cancer	0.000495	0.00617	CcSEcCtD
Clobazam—Tremor—Cisplatin—bone cancer	0.000492	0.00614	CcSEcCtD
Clobazam—Ketazolam—CYP3A4—bone cancer	0.000489	0.0565	CrCbGaD
Clobazam—Lethargy—Methotrexate—bone cancer	0.000488	0.00609	CcSEcCtD
Clobazam—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000485	0.0103	CbGpPWpGaD
Clobazam—Anaemia—Cisplatin—bone cancer	0.000485	0.00605	CcSEcCtD
Clobazam—CYP2C18—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000484	0.0102	CbGpPWpGaD
Clobazam—Osteoarthritis—Methotrexate—bone cancer	0.000478	0.00597	CcSEcCtD
Clobazam—Increased appetite—Epirubicin—bone cancer	0.000476	0.00594	CcSEcCtD
Clobazam—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000476	0.0101	CbGpPWpGaD
Clobazam—Oxcarbazepine—CYP3A4—bone cancer	0.000476	0.0549	CrCbGaD
Clobazam—Leukopenia—Cisplatin—bone cancer	0.00047	0.00586	CcSEcCtD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000462	0.00978	CbGpPWpGaD
Clobazam—Lethargy—Epirubicin—bone cancer	0.000457	0.0057	CcSEcCtD
Clobazam—Irritability—Methotrexate—bone cancer	0.000456	0.0057	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000454	0.00962	CbGpPWpGaD
Clobazam—Phenylbutazone—CYP3A4—bone cancer	0.000453	0.0524	CrCbGaD
Clobazam—Ataxia—Methotrexate—bone cancer	0.00045	0.00561	CcSEcCtD
Clobazam—Osteoarthritis—Epirubicin—bone cancer	0.000447	0.00559	CcSEcCtD
Clobazam—Diplopia—Epirubicin—bone cancer	0.000447	0.00559	CcSEcCtD
Clobazam—Myalgia—Cisplatin—bone cancer	0.000447	0.00558	CcSEcCtD
Clobazam—Anxiety—Cisplatin—bone cancer	0.000445	0.00556	CcSEcCtD
Clobazam—Phenylbutazone—PTGS2—bone cancer	0.000444	0.0513	CrCbGaD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000444	0.00554	CcSEcCtD
Clobazam—Liver function test abnormal—Methotrexate—bone cancer	0.000441	0.00551	CcSEcCtD
Clobazam—Increased appetite—Doxorubicin—bone cancer	0.000441	0.0055	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000431	0.00537	CcSEcCtD
Clobazam—Infection—Cisplatin—bone cancer	0.000425	0.00531	CcSEcCtD
Clobazam—SLC6A11—Metabolism—NT5C3A—bone cancer	0.000423	0.00895	CbGpPWpGaD
Clobazam—Lethargy—Doxorubicin—bone cancer	0.000423	0.00527	CcSEcCtD
Clobazam—Ataxia—Epirubicin—bone cancer	0.000421	0.00525	CcSEcCtD
Clobazam—Nervous system disorder—Cisplatin—bone cancer	0.00042	0.00524	CcSEcCtD
Clobazam—Thrombocytopenia—Cisplatin—bone cancer	0.000419	0.00523	CcSEcCtD
Clobazam—Skin disorder—Cisplatin—bone cancer	0.000416	0.00519	CcSEcCtD
Clobazam—SLC6A11—Transmission across Chemical Synapses—BRAF—bone cancer	0.000414	0.00877	CbGpPWpGaD
Clobazam—Diplopia—Doxorubicin—bone cancer	0.000414	0.00517	CcSEcCtD
Clobazam—Osteoarthritis—Doxorubicin—bone cancer	0.000414	0.00517	CcSEcCtD
Clobazam—Hyperhidrosis—Cisplatin—bone cancer	0.000414	0.00517	CcSEcCtD
Clobazam—Asthma—Methotrexate—bone cancer	0.000413	0.00516	CcSEcCtD
Clobazam—Liver function test abnormal—Epirubicin—bone cancer	0.000413	0.00516	CcSEcCtD
Clobazam—Eosinophilia—Methotrexate—bone cancer	0.000409	0.00511	CcSEcCtD
Clobazam—Anorexia—Cisplatin—bone cancer	0.000408	0.0051	CcSEcCtD
Clobazam—Chlordiazepoxide—CYP3A4—bone cancer	0.000408	0.0471	CrCbGaD
Clobazam—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000403	0.00503	CcSEcCtD
Clobazam—Hypotension—Cisplatin—bone cancer	0.0004	0.00499	CcSEcCtD
Clobazam—Muscular weakness—Epirubicin—bone cancer	0.000395	0.00493	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00039	0.00487	CcSEcCtD
Clobazam—Abdominal distension—Epirubicin—bone cancer	0.000389	0.00486	CcSEcCtD
Clobazam—Ataxia—Doxorubicin—bone cancer	0.000389	0.00486	CcSEcCtD
Clobazam—Asthma—Epirubicin—bone cancer	0.000387	0.00483	CcSEcCtD
Clobazam—Dysphagia—Epirubicin—bone cancer	0.000387	0.00483	CcSEcCtD
Clobazam—Upper respiratory tract infection—Methotrexate—bone cancer	0.000384	0.00479	CcSEcCtD
Clobazam—Eosinophilia—Epirubicin—bone cancer	0.000383	0.00478	CcSEcCtD
Clobazam—Liver function test abnormal—Doxorubicin—bone cancer	0.000382	0.00477	CcSEcCtD
Clobazam—Clorazepate—CYP3A4—bone cancer	0.000382	0.0441	CrCbGaD
Clobazam—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000373	0.00465	CcSEcCtD
Clobazam—Decreased appetite—Cisplatin—bone cancer	0.000372	0.00465	CcSEcCtD
Clobazam—Bronchitis—Epirubicin—bone cancer	0.000372	0.00464	CcSEcCtD
Clobazam—Pneumonia—Methotrexate—bone cancer	0.000371	0.00463	CcSEcCtD
Clobazam—Gastrointestinal disorder—Cisplatin—bone cancer	0.00037	0.00461	CcSEcCtD
Clobazam—Drowsiness—Methotrexate—bone cancer	0.000368	0.0046	CcSEcCtD
Clobazam—Infestation—Methotrexate—bone cancer	0.000368	0.0046	CcSEcCtD
Clobazam—Infestation NOS—Methotrexate—bone cancer	0.000368	0.0046	CcSEcCtD
Clobazam—Depression—Methotrexate—bone cancer	0.000367	0.00459	CcSEcCtD
Clobazam—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000367	0.00776	CbGpPWpGaD
Clobazam—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000365	0.00456	CcSEcCtD
Clobazam—Muscular weakness—Doxorubicin—bone cancer	0.000365	0.00456	CcSEcCtD
Clobazam—Abdominal distension—Doxorubicin—bone cancer	0.00036	0.0045	CcSEcCtD
Clobazam—Upper respiratory tract infection—Epirubicin—bone cancer	0.000359	0.00449	CcSEcCtD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000359	0.00761	CbGpPWpGaD
Clobazam—Dysphagia—Doxorubicin—bone cancer	0.000358	0.00447	CcSEcCtD
Clobazam—Asthma—Doxorubicin—bone cancer	0.000358	0.00447	CcSEcCtD
Clobazam—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000358	0.00757	CbGpPWpGaD
Clobazam—Eosinophilia—Doxorubicin—bone cancer	0.000354	0.00442	CcSEcCtD
Clobazam—Sweating—Methotrexate—bone cancer	0.000353	0.00441	CcSEcCtD
Clobazam—Feeling abnormal—Cisplatin—bone cancer	0.000353	0.0044	CcSEcCtD
Clobazam—Weight increased—Epirubicin—bone cancer	0.000352	0.00439	CcSEcCtD
Clobazam—SLC6A11—Transmission across Chemical Synapses—MDM2—bone cancer	0.000347	0.00734	CbGpPWpGaD
Clobazam—Pneumonia—Epirubicin—bone cancer	0.000347	0.00433	CcSEcCtD
Clobazam—Alprazolam—CYP3A4—bone cancer	0.000345	0.0399	CrCbGaD
Clobazam—Infestation NOS—Epirubicin—bone cancer	0.000345	0.0043	CcSEcCtD
Clobazam—Infestation—Epirubicin—bone cancer	0.000345	0.0043	CcSEcCtD
Clobazam—Drowsiness—Epirubicin—bone cancer	0.000345	0.0043	CcSEcCtD
Clobazam—Bronchitis—Doxorubicin—bone cancer	0.000344	0.0043	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000342	0.00427	CcSEcCtD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000341	0.00722	CbGpPWpGaD
Clobazam—CYP2C18—Tryptophan metabolism—MDM2—bone cancer	0.000339	0.00718	CbGpPWpGaD
Clobazam—Body temperature increased—Cisplatin—bone cancer	0.000339	0.00423	CcSEcCtD
Clobazam—Urinary tract infection—Epirubicin—bone cancer	0.000335	0.00418	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000334	0.00707	CbGpPWpGaD
Clobazam—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000333	0.00415	CcSEcCtD
Clobazam—Sweating—Epirubicin—bone cancer	0.000331	0.00413	CcSEcCtD
Clobazam—Prochlorperazine—CYP3A4—bone cancer	0.00033	0.0381	CrCbGaD
Clobazam—Weight increased—Doxorubicin—bone cancer	0.000326	0.00406	CcSEcCtD
Clobazam—Pneumonia—Doxorubicin—bone cancer	0.000321	0.00401	CcSEcCtD
Clobazam—Infestation—Doxorubicin—bone cancer	0.000319	0.00398	CcSEcCtD
Clobazam—Drowsiness—Doxorubicin—bone cancer	0.000319	0.00398	CcSEcCtD
Clobazam—Infestation NOS—Doxorubicin—bone cancer	0.000319	0.00398	CcSEcCtD
Clobazam—Visual impairment—Methotrexate—bone cancer	0.000319	0.00398	CcSEcCtD
Clobazam—SLC6A11—Neuronal System—BRAF—bone cancer	0.000317	0.00672	CbGpPWpGaD
Clobazam—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000316	0.00395	CcSEcCtD
Clobazam—Flunitrazepam—CYP3A4—bone cancer	0.000316	0.0365	CrCbGaD
Clobazam—Erythema multiforme—Methotrexate—bone cancer	0.000313	0.0039	CcSEcCtD
Clobazam—Urinary tract infection—Doxorubicin—bone cancer	0.00031	0.00387	CcSEcCtD
Clobazam—Eye disorder—Methotrexate—bone cancer	0.000309	0.00386	CcSEcCtD
Clobazam—Asthenia—Cisplatin—bone cancer	0.000307	0.00384	CcSEcCtD
Clobazam—Sweating—Doxorubicin—bone cancer	0.000306	0.00382	CcSEcCtD
Clobazam—CYP2C18—FOXA1 transcription factor network—JUN—bone cancer	0.000306	0.00647	CbGpPWpGaD
Clobazam—Visual impairment—Epirubicin—bone cancer	0.000298	0.00372	CcSEcCtD
Clobazam—Estazolam—CYP3A4—bone cancer	0.000296	0.0342	CrCbGaD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000293	0.00621	CbGpPWpGaD
Clobazam—Diarrhoea—Cisplatin—bone cancer	0.000293	0.00366	CcSEcCtD
Clobazam—Erythema multiforme—Epirubicin—bone cancer	0.000293	0.00365	CcSEcCtD
Clobazam—Mental disorder—Methotrexate—bone cancer	0.00029	0.00362	CcSEcCtD
Clobazam—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00029	0.00613	CbGpPWpGaD
Clobazam—Eye disorder—Epirubicin—bone cancer	0.000289	0.00361	CcSEcCtD
Clobazam—Malnutrition—Methotrexate—bone cancer	0.000288	0.00359	CcSEcCtD
Clobazam—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000286	0.00606	CbGpPWpGaD
Clobazam—Adinazolam—CYP3A4—bone cancer	0.000282	0.0325	CrCbGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—MDM2—bone cancer	0.00028	0.00592	CbGpPWpGaD
Clobazam—Visual impairment—Doxorubicin—bone cancer	0.000276	0.00345	CcSEcCtD
Clobazam—Clomipramine—CYP3A4—bone cancer	0.000273	0.0316	CrCbGaD
Clobazam—Vomiting—Cisplatin—bone cancer	0.000272	0.0034	CcSEcCtD
Clobazam—Prazepam—CYP3A4—bone cancer	0.000272	0.0315	CrCbGaD
Clobazam—Vision blurred—Methotrexate—bone cancer	0.000271	0.00339	CcSEcCtD
Clobazam—Mental disorder—Epirubicin—bone cancer	0.000271	0.00338	CcSEcCtD
Clobazam—Erythema multiforme—Doxorubicin—bone cancer	0.000271	0.00338	CcSEcCtD
Clobazam—Rash—Cisplatin—bone cancer	0.00027	0.00337	CcSEcCtD
Clobazam—Dermatitis—Cisplatin—bone cancer	0.00027	0.00337	CcSEcCtD
Clobazam—Malnutrition—Epirubicin—bone cancer	0.000269	0.00336	CcSEcCtD
Clobazam—Eye disorder—Doxorubicin—bone cancer	0.000268	0.00334	CcSEcCtD
Clobazam—Anaemia—Methotrexate—bone cancer	0.000266	0.00332	CcSEcCtD
Clobazam—SLC6A11—Neuronal System—MDM2—bone cancer	0.000266	0.00563	CbGpPWpGaD
Clobazam—Tension—Epirubicin—bone cancer	0.000264	0.0033	CcSEcCtD
Clobazam—Nervousness—Epirubicin—bone cancer	0.000262	0.00327	CcSEcCtD
Clobazam—Muscle spasms—Epirubicin—bone cancer	0.000259	0.00323	CcSEcCtD
Clobazam—Leukopenia—Methotrexate—bone cancer	0.000258	0.00322	CcSEcCtD
Clobazam—CYP2C18—Biological oxidations—CYP3A4—bone cancer	0.000257	0.00544	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—BRAF—bone cancer	0.000256	0.00541	CbGpPWpGaD
Clobazam—Nausea—Cisplatin—bone cancer	0.000254	0.00318	CcSEcCtD
Clobazam—Vision blurred—Epirubicin—bone cancer	0.000254	0.00317	CcSEcCtD
Clobazam—Flurazepam—CYP3A4—bone cancer	0.000254	0.0293	CrCbGaD
Clobazam—Triazolam—CYP3A4—bone cancer	0.000254	0.0293	CrCbGaD
Clobazam—CYP2C18—Metapathway biotransformation—CYP3A4—bone cancer	0.000253	0.00536	CbGpPWpGaD
Clobazam—Cough—Methotrexate—bone cancer	0.000251	0.00314	CcSEcCtD
Clobazam—Mental disorder—Doxorubicin—bone cancer	0.000251	0.00313	CcSEcCtD
Clobazam—Malnutrition—Doxorubicin—bone cancer	0.000249	0.00311	CcSEcCtD
Clobazam—Anaemia—Epirubicin—bone cancer	0.000249	0.00311	CcSEcCtD
Clobazam—Agitation—Epirubicin—bone cancer	0.000248	0.00309	CcSEcCtD
Clobazam—Oxazepam—CYP3A4—bone cancer	0.000246	0.0284	CrCbGaD
Clobazam—Myalgia—Methotrexate—bone cancer	0.000245	0.00306	CcSEcCtD
Clobazam—Tension—Doxorubicin—bone cancer	0.000245	0.00305	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000243	0.00304	CcSEcCtD
Clobazam—Temazepam—CYP3A4—bone cancer	0.000243	0.028	CrCbGaD
Clobazam—Nervousness—Doxorubicin—bone cancer	0.000242	0.00302	CcSEcCtD
Clobazam—Leukopenia—Epirubicin—bone cancer	0.000241	0.00301	CcSEcCtD
Clobazam—Muscle spasms—Doxorubicin—bone cancer	0.00024	0.00299	CcSEcCtD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000238	0.00503	CbGpPWpGaD
Clobazam—Confusional state—Methotrexate—bone cancer	0.000237	0.00296	CcSEcCtD
Clobazam—Midazolam—CYP3A4—bone cancer	0.000235	0.0272	CrCbGaD
Clobazam—Cough—Epirubicin—bone cancer	0.000235	0.00293	CcSEcCtD
Clobazam—Vision blurred—Doxorubicin—bone cancer	0.000235	0.00293	CcSEcCtD
Clobazam—Infection—Methotrexate—bone cancer	0.000233	0.00291	CcSEcCtD
Clobazam—Nervous system disorder—Methotrexate—bone cancer	0.00023	0.00288	CcSEcCtD
Clobazam—Anaemia—Doxorubicin—bone cancer	0.00023	0.00288	CcSEcCtD
Clobazam—Thrombocytopenia—Methotrexate—bone cancer	0.00023	0.00287	CcSEcCtD
Clobazam—Myalgia—Epirubicin—bone cancer	0.000229	0.00286	CcSEcCtD
Clobazam—Agitation—Doxorubicin—bone cancer	0.000229	0.00286	CcSEcCtD
Clobazam—Anxiety—Epirubicin—bone cancer	0.000229	0.00285	CcSEcCtD
Clobazam—Skin disorder—Methotrexate—bone cancer	0.000228	0.00285	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000228	0.00284	CcSEcCtD
Clobazam—Hyperhidrosis—Methotrexate—bone cancer	0.000227	0.00284	CcSEcCtD
Clobazam—Dry mouth—Epirubicin—bone cancer	0.000224	0.0028	CcSEcCtD
Clobazam—Anorexia—Methotrexate—bone cancer	0.000224	0.0028	CcSEcCtD
Clobazam—Leukopenia—Doxorubicin—bone cancer	0.000223	0.00279	CcSEcCtD
Clobazam—Confusional state—Epirubicin—bone cancer	0.000222	0.00277	CcSEcCtD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000222	0.00469	CbGpPWpGaD
Clobazam—CYP2C18—Biological oxidations—GSTP1—bone cancer	0.00022	0.00465	CbGpPWpGaD
Clobazam—Hypotension—Methotrexate—bone cancer	0.00022	0.00274	CcSEcCtD
Clobazam—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000219	0.00463	CbGpPWpGaD
Clobazam—Infection—Epirubicin—bone cancer	0.000218	0.00273	CcSEcCtD
Clobazam—Cough—Doxorubicin—bone cancer	0.000218	0.00272	CcSEcCtD
Clobazam—CYP2C18—Metapathway biotransformation—GSTP1—bone cancer	0.000217	0.00459	CbGpPWpGaD
Clobazam—Nervous system disorder—Epirubicin—bone cancer	0.000216	0.00269	CcSEcCtD
Clobazam—Thrombocytopenia—Epirubicin—bone cancer	0.000215	0.00269	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—MDM2—bone cancer	0.000214	0.00454	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000214	0.00267	CcSEcCtD
Clobazam—Skin disorder—Epirubicin—bone cancer	0.000214	0.00267	CcSEcCtD
Clobazam—Hyperhidrosis—Epirubicin—bone cancer	0.000213	0.00265	CcSEcCtD
Clobazam—Insomnia—Methotrexate—bone cancer	0.000213	0.00265	CcSEcCtD
Clobazam—Myalgia—Doxorubicin—bone cancer	0.000212	0.00265	CcSEcCtD
Clobazam—Anxiety—Doxorubicin—bone cancer	0.000212	0.00264	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000211	0.00263	CcSEcCtD
Clobazam—Anorexia—Epirubicin—bone cancer	0.00021	0.00262	CcSEcCtD
Clobazam—Somnolence—Methotrexate—bone cancer	0.000209	0.00261	CcSEcCtD
Clobazam—Dry mouth—Doxorubicin—bone cancer	0.000208	0.00259	CcSEcCtD
Clobazam—Hypotension—Epirubicin—bone cancer	0.000206	0.00256	CcSEcCtD
Clobazam—Confusional state—Doxorubicin—bone cancer	0.000205	0.00256	CcSEcCtD
Clobazam—Decreased appetite—Methotrexate—bone cancer	0.000204	0.00255	CcSEcCtD
Clobazam—Gastrointestinal disorder—Methotrexate—bone cancer	0.000203	0.00253	CcSEcCtD
Clobazam—Fatigue—Methotrexate—bone cancer	0.000203	0.00253	CcSEcCtD
Clobazam—Infection—Doxorubicin—bone cancer	0.000202	0.00252	CcSEcCtD
Clobazam—Diazepam—CYP3A4—bone cancer	0.000202	0.0233	CrCbGaD
Clobazam—Musculoskeletal discomfort—Epirubicin—bone cancer	0.0002	0.0025	CcSEcCtD
Clobazam—Nervous system disorder—Doxorubicin—bone cancer	0.0002	0.00249	CcSEcCtD
Clobazam—Thrombocytopenia—Doxorubicin—bone cancer	0.000199	0.00249	CcSEcCtD
Clobazam—Clozapine—CYP3A4—bone cancer	0.000199	0.023	CrCbGaD
Clobazam—Insomnia—Epirubicin—bone cancer	0.000199	0.00248	CcSEcCtD
Clobazam—Skin disorder—Doxorubicin—bone cancer	0.000198	0.00247	CcSEcCtD
Clobazam—Hyperhidrosis—Doxorubicin—bone cancer	0.000197	0.00246	CcSEcCtD
Clobazam—Somnolence—Epirubicin—bone cancer	0.000196	0.00244	CcSEcCtD
Clobazam—Anorexia—Doxorubicin—bone cancer	0.000194	0.00242	CcSEcCtD
Clobazam—Feeling abnormal—Methotrexate—bone cancer	0.000194	0.00242	CcSEcCtD
Clobazam—Decreased appetite—Epirubicin—bone cancer	0.000191	0.00239	CcSEcCtD
Clobazam—Hypotension—Doxorubicin—bone cancer	0.00019	0.00237	CcSEcCtD
Clobazam—Gastrointestinal disorder—Epirubicin—bone cancer	0.00019	0.00237	CcSEcCtD
Clobazam—Fatigue—Epirubicin—bone cancer	0.00019	0.00237	CcSEcCtD
Clobazam—Constipation—Epirubicin—bone cancer	0.000188	0.00235	CcSEcCtD
Clobazam—Chlorpromazine—CYP3A4—bone cancer	0.000187	0.0216	CrCbGaD
Clobazam—Urticaria—Methotrexate—bone cancer	0.000187	0.00233	CcSEcCtD
Clobazam—Body temperature increased—Methotrexate—bone cancer	0.000186	0.00232	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000185	0.00231	CcSEcCtD
Clobazam—SLC6A11—Metabolism—ENO2—bone cancer	0.000185	0.00392	CbGpPWpGaD
Clobazam—Insomnia—Doxorubicin—bone cancer	0.000184	0.0023	CcSEcCtD
Clobazam—Feeling abnormal—Epirubicin—bone cancer	0.000181	0.00226	CcSEcCtD
Clobazam—Somnolence—Doxorubicin—bone cancer	0.000181	0.00226	CcSEcCtD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00018	0.0038	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000178	0.00377	CbGpPWpGaD
Clobazam—Decreased appetite—Doxorubicin—bone cancer	0.000177	0.00221	CcSEcCtD
Clobazam—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000176	0.00219	CcSEcCtD
Clobazam—Fatigue—Doxorubicin—bone cancer	0.000175	0.00219	CcSEcCtD
Clobazam—Urticaria—Epirubicin—bone cancer	0.000175	0.00218	CcSEcCtD
Clobazam—Constipation—Doxorubicin—bone cancer	0.000174	0.00217	CcSEcCtD
Clobazam—Body temperature increased—Epirubicin—bone cancer	0.000174	0.00217	CcSEcCtD
Clobazam—SLC6A11—Metabolism—DHFR—bone cancer	0.000172	0.00364	CbGpPWpGaD
Clobazam—Asthenia—Methotrexate—bone cancer	0.000169	0.0021	CcSEcCtD
Clobazam—Feeling abnormal—Doxorubicin—bone cancer	0.000168	0.00209	CcSEcCtD
Clobazam—Pruritus—Methotrexate—bone cancer	0.000166	0.00208	CcSEcCtD
Clobazam—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000163	0.00345	CbGpPWpGaD
Clobazam—Urticaria—Doxorubicin—bone cancer	0.000162	0.00202	CcSEcCtD
Clobazam—Body temperature increased—Doxorubicin—bone cancer	0.000161	0.00201	CcSEcCtD
Clobazam—Diarrhoea—Methotrexate—bone cancer	0.000161	0.00201	CcSEcCtD
Clobazam—SLC6A11—Metabolism—GNA11—bone cancer	0.000161	0.0034	CbGpPWpGaD
Clobazam—Asthenia—Epirubicin—bone cancer	0.000158	0.00197	CcSEcCtD
Clobazam—Pruritus—Epirubicin—bone cancer	0.000156	0.00194	CcSEcCtD
Clobazam—Dizziness—Methotrexate—bone cancer	0.000155	0.00194	CcSEcCtD
Clobazam—CYP2C18—Metabolism—NDUFA12—bone cancer	0.000154	0.00326	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000154	0.00326	CbGpPWpGaD
Clobazam—Diarrhoea—Epirubicin—bone cancer	0.00015	0.00188	CcSEcCtD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00015	0.00318	CbGpPWpGaD
Clobazam—Vomiting—Methotrexate—bone cancer	0.000149	0.00186	CcSEcCtD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000148	0.00314	CbGpPWpGaD
Clobazam—Rash—Methotrexate—bone cancer	0.000148	0.00185	CcSEcCtD
Clobazam—Dermatitis—Methotrexate—bone cancer	0.000148	0.00185	CcSEcCtD
Clobazam—Headache—Methotrexate—bone cancer	0.000147	0.00184	CcSEcCtD
Clobazam—Asthenia—Doxorubicin—bone cancer	0.000146	0.00182	CcSEcCtD
Clobazam—SLC6A11—Metabolism—CYP3A4—bone cancer	0.000146	0.00308	CbGpPWpGaD
Clobazam—Dizziness—Epirubicin—bone cancer	0.000145	0.00182	CcSEcCtD
Clobazam—Pruritus—Doxorubicin—bone cancer	0.000144	0.0018	CcSEcCtD
Clobazam—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000142	0.00302	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000141	0.00298	CbGpPWpGaD
Clobazam—Vomiting—Epirubicin—bone cancer	0.00014	0.00175	CcSEcCtD
Clobazam—Nausea—Methotrexate—bone cancer	0.00014	0.00174	CcSEcCtD
Clobazam—Diarrhoea—Doxorubicin—bone cancer	0.000139	0.00174	CcSEcCtD
Clobazam—Rash—Epirubicin—bone cancer	0.000139	0.00173	CcSEcCtD
Clobazam—Dermatitis—Epirubicin—bone cancer	0.000139	0.00173	CcSEcCtD
Clobazam—Headache—Epirubicin—bone cancer	0.000138	0.00172	CcSEcCtD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000137	0.00291	CbGpPWpGaD
Clobazam—Dizziness—Doxorubicin—bone cancer	0.000135	0.00168	CcSEcCtD
Clobazam—Nausea—Epirubicin—bone cancer	0.000131	0.00163	CcSEcCtD
Clobazam—Vomiting—Doxorubicin—bone cancer	0.000129	0.00161	CcSEcCtD
Clobazam—Rash—Doxorubicin—bone cancer	0.000128	0.0016	CcSEcCtD
Clobazam—Dermatitis—Doxorubicin—bone cancer	0.000128	0.0016	CcSEcCtD
Clobazam—CYP2C18—Metabolism—NT5C3A—bone cancer	0.000128	0.0027	CbGpPWpGaD
Clobazam—Headache—Doxorubicin—bone cancer	0.000127	0.00159	CcSEcCtD
Clobazam—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000126	0.00267	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000126	0.00267	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000125	0.00264	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—GSTP1—bone cancer	0.000125	0.00264	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000123	0.0026	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000122	0.00257	CbGpPWpGaD
Clobazam—Nausea—Doxorubicin—bone cancer	0.000121	0.00151	CcSEcCtD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00012	0.00254	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000115	0.00244	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000114	0.00241	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000113	0.00239	CbGpPWpGaD
Clobazam—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000108	0.00229	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000107	0.00226	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000103	0.00219	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000103	0.00219	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000101	0.00213	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—CYP3A4—bone cancer	9.55e-05	0.00202	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	9.47e-05	0.002	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	9.42e-05	0.00199	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.41e-05	0.00199	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	9.03e-05	0.00191	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	8.66e-05	0.00183	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—BRAF—bone cancer	8.66e-05	0.00183	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	8.57e-05	0.00181	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.45e-05	0.00179	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.16e-05	0.00173	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.05e-05	0.0017	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	8.02e-05	0.0017	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.01e-05	0.0017	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—BRAF—bone cancer	7.92e-05	0.00168	CbGpPWpGaD
Clobazam—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.58e-05	0.0016	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NDUFA12—bone cancer	7.57e-05	0.0016	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	7.57e-05	0.0016	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—MDM2—bone cancer	7.25e-05	0.00154	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.16e-05	0.00152	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.14e-05	0.00151	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—BRAF—bone cancer	6.92e-05	0.00147	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—MDM2—bone cancer	6.63e-05	0.0014	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTGS2—bone cancer	6.45e-05	0.00137	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NT5C3A—bone cancer	6.27e-05	0.00133	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.17e-05	0.00131	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—MDM2—bone cancer	5.8e-05	0.00123	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NDUFA12—bone cancer	5.72e-05	0.00121	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—ENO2—bone cancer	5.59e-05	0.00118	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NDUFA12—bone cancer	5.59e-05	0.00118	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.31e-05	0.00112	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—DHFR—bone cancer	5.19e-05	0.0011	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.91e-05	0.00104	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GNA11—bone cancer	4.85e-05	0.00103	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.84e-05	0.00103	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NT5C3A—bone cancer	4.74e-05	0.001	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NT5C3A—bone cancer	4.63e-05	0.00098	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CYP3A4—bone cancer	4.39e-05	0.00093	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.94e-05	0.000834	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.8e-05	0.000804	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GSTP1—bone cancer	3.76e-05	0.000796	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NDUFA12—bone cancer	3.44e-05	0.000728	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.42e-05	0.000725	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NT5C3A—bone cancer	2.85e-05	0.000604	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—ENO2—bone cancer	2.75e-05	0.000582	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.69e-05	0.00057	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—DHFR—bone cancer	2.55e-05	0.00054	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GNA11—bone cancer	2.38e-05	0.000504	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.26e-05	0.000478	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYP3A4—bone cancer	2.16e-05	0.000457	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—ENO2—bone cancer	2.08e-05	0.00044	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—ENO2—bone cancer	2.03e-05	0.000429	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTGS2—bone cancer	1.95e-05	0.000412	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—DHFR—bone cancer	1.93e-05	0.000408	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—DHFR—bone cancer	1.88e-05	0.000398	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GSTP1—bone cancer	1.85e-05	0.000391	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GNA11—bone cancer	1.8e-05	0.000381	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GNA11—bone cancer	1.76e-05	0.000372	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYP3A4—bone cancer	1.63e-05	0.000346	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.62e-05	0.000344	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYP3A4—bone cancer	1.59e-05	0.000337	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GSTP1—bone cancer	1.4e-05	0.000296	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GSTP1—bone cancer	1.36e-05	0.000289	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—ENO2—bone cancer	1.25e-05	0.000264	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—DHFR—bone cancer	1.16e-05	0.000245	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GNA11—bone cancer	1.08e-05	0.000229	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTGS2—bone cancer	9.57e-06	0.000203	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GSTP1—bone cancer	8.4e-06	0.000178	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTGS2—bone cancer	7.23e-06	0.000153	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTGS2—bone cancer	7.06e-06	0.000149	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTGS2—bone cancer	4.35e-06	9.21e-05	CbGpPWpGaD
